Delaloge S, Cella D, Ye Y, Buyse M, et al. Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial. Ann Oncol 2019;30:567-574.
PMID: 31987273